Ramesh Ramakrishnan files SEC Form 4 disclosures for Talis Biomedical Corp. They have made 2 open-market trades across 1 company since 2021, most recently 2021-08-13.
CIK 0001845434
1 open-market purchase totalling $16K since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TLIS | 38,619 | $169K |
Shares reported on the most recent Form 4, priced at the 2021-08-17 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.